SanBio Company Limited
SNBIF · OTC
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,010,666 | -$2,542,135 | -$4,697,443 | -$4,560,423 |
| Dep. & Amort. | $9,368 | $14,504 | $24,615 | $132,467 |
| Deferred Tax | $0 | -$29,042 | -$3,492,918 | -$2,309,990 |
| Stock-Based Comp. | $19,238 | $0 | $102,978 | $141,241 |
| Change in WC | -$66,958 | -$445,118 | $468,833 | $35,971 |
| Other Non-Cash | -$554,088 | -$1,763,863 | $159,788 | $14,070 |
| Operating Cash Flow | -$3,603,106 | -$4,765,654 | -$7,434,147 | -$6,546,664 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4,891 | -$11,078 | -$8,003 | -$56,077 |
| Net Acquisitions | $0 | $0 | $1,434 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $624 | -$7,950 | -$3,531 | -$10,184 |
| Investing Cash Flow | -$4,267 | -$19,028 | -$10,100 | -$66,261 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$268,000 | -$268,000 | -$1,592,000 | -$1,475,000 |
| Stock Issued | $2,372,805 | $2,651,366 | $10,956,657 | $3,749 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$13,800 | -$12,834 | $81,126 | -$24,233 |
| Financing Cash Flow | $2,091,005 | $2,370,532 | $9,445,783 | -$1,495,484 |
| Forex Effect | -$20,019 | $128,472 | $116,655 | $185,250 |
| Net Chg. in Cash | -$1,536,388 | -$2,285,678 | $2,118,192 | -$7,923,159 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,389,520 | $6,675,198 | $4,557,006 | $12,480,165 |
| End Cash | $2,853,132 | $4,389,520 | $6,675,198 | $4,557,006 |
| Free Cash Flow | -$3,607,997 | -$4,820,623 | -$7,442,150 | -$6,602,741 |